<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-12018</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Report of two cases os sudden deafness in patients bearing of sickle cell anaemia and trait</dc:title>
<dc:description xml:lang="en">We report two cases of sudden deafness which appeared during vaso-occlusive crisis of a sickle cell anaemia (homozygous form of disease) and a sickle cell trait (heterozygous form) in two males aged sixteen and twenty-two, respectively. A high erythrocyte aggregability and low deformability were proved in both young men. Although hearing disorders have been reported in this disease, a sudden onset is not common. The treatment used was useful in the removal of painful crisis and infections, but deafness did not improve in either of then (AU)</dc:description>
<dc:publisher>Sanidad y Ediciones (SANED, S.L.)</dc:publisher>
<dc:description xml:lang="es">Presentamos los dos casos de sordera súbita acontecidos durante el desarrollo de sendas crisis vasooclusivas en el contexto de una anemia de células falciformes (forma homocigota de la drepanocitosis) y de un rasgo drepanocítico (forma heterocigota) en dos varones de 16 y 22 años de edad, respectivamente. En ambos casos se constató el aumento en la agregabilidad de los eritrocitos y la disminución en su deformabilidad. Aunque está reconocida la afectación auditiva en esta enfermedad, la rapidez de instauración es rara. El tratamiento empleado alivió las crisis dolorosas y erradicó las infecciones, pero la hipoacusia resultó irreversible (AU)</dc:description>
<dc:source>Acta Otorrinolaringol Esp;53(5): 371-376, mayo 2002. ilus, graf</dc:source>
<dc:title xml:lang="es">Presentación de dos casos de sordera súbita en pacientes afectos de anemia y rasgo drepanocíticos</dc:title>
<dc:type>article</dc:type>
<dc:creator>García Callejo, FJ</dc:creator>
<dc:creator>Marco Algarra, J</dc:creator>
<dc:creator>Sebastián Gil, E</dc:creator>
<dc:creator>Morant Ventura, A</dc:creator>
<dc:language>es</dc:language>
<dc:identifier>ibc-12018</dc:identifier>
<dc:subject>^d3655^s22027</dc:subject>
<dc:subject>^d13186^s22012</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d4990</dc:subject>
<dc:subject>^d4994</dc:subject>
<dc:subject>^d24557</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d768</dc:subject>
<dc:subject>^d3656</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d24501^s22027</dc:subject>
<dc:subject>^d10199</dc:subject>
<dc:subject>^d13590</dc:subject>
<dc:subject>^d6471</dc:subject>
<dc:date>200205</dc:date>
</metadata>
</record>
</ibecs-document>
